Okay, let's tackle this question. The patient is hemodynamically stable with an adnexal mass, beta hCG of 1500, and no intrauterine gestational sac. So, first, I need to figure out what condition she might have. Since there's an adnexal mass and no intrauterine sac, ectopic pregnancy comes to mind. Beta hCG levels are rising, but not seeing a gestational sac raises the suspicion.

Now, the options for treatment. The question is about the modality suitable. For ectopic pregnancies, management depends on stability. Since she's stable, maybe medical management is possible. Methotrexate is an option when certain criteria are met. Let me recall the criteria: beta hCG less than 5000, no fetal heart activity, no contraindications to MTX. Also, the adnexal mass should be less than 3.5-4 cm. The mass here is 2.5x3 cm, which is under 4 cm. So MTX might be appropriate here.

Wait, but beta hCG is 1500. The criteria usually require less than 5000. So 1500 is within range. Also, she's stable, so no need for emergency surgery. So the correct answer would be methotrexate. The other options might be surgery (laparoscopic salpingectomy or salpingostomy) if the patient is unstable or if the mass is too large. But here, since she's stable and meets the criteria, medical management is suitable.

Now, the wrong options. Let's say options A, B, C, D are other treatments. Let's assume the options include surgery, observation, other meds, etc. For example, if an option is laparoscopic surgery, that's incorrect here because the patient is stable and meets medical criteria. Another option might be expectant management, but if hCG is rising, that's not suitable. Another option could be another medication like misoprostol, which isn't used for ectopic. So each incorrect option's reason would be based on not meeting the criteria for medical management or being inappropriate for the situation.

The clinical pearl here is the criteria for methotrexate use in ectopic pregnancy. Remembering the key points: beta hCG <5000, no fetal heart, adnexal mass <4 cm, stable patient. Also, the need to confirm with serial hCG levels after treatment. That's a high-yield fact for exams.

**Core Concept**
This question tests the management of ectopic pregnancy, focusing on criteria for medical versus surgical intervention. Key factors include beta hCG levels, adnexal mass size, and hemodynamic stability.

**Why the Correct Answer is Right**
The patient meets criteria for **medical management with methotrexate**: beta hCG <5000 mIU/mL (1500), adnexal mass <4 cm (2.5x3 cm), no intrauterine gestational sac, and hemodynamic stability. Methotrexate is effective in early ectopic pregnancies with these parameters, avoiding surgery. It inhibits dihydrofolate reductase, halting trophoblastic growth. **Why Each Wrong Option is Incorrect** **Option A:** Laparoscopic salpingectomy

✓ Correct Answer: B. Medical management